The German pharmaceutical industry has long been warning of the serious consequences of the new savings plans for the drug location Germany. A company is now seeking help from Germany's highest court.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Karlsruhe – The dispute over the German Federal Constitutional Court (BVerfG) regarding the GKV contribution rate stabilization law. The pharmaceutical company MSD – the German subsidiary of the US-group Merck – filed a constitutional complaint against central regulations of the law in Karlsruhe last week. A spokesman of the BVerfG confirmed the...
The German pharmaceutical industry has long been warning of the serious consequences of the new savings plans for the drug location Germany. A company is now seeking help from Germany's highest court.